Trial Profile
Phase 2 trial of Abraxane, albumin-bound paclitaxel, in patients with previously treated non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2017
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 23 Jan 2017 Status changed from active, no longer recruiting to completed.
- 14 Jun 2013 New trial record